default author photo

Seigo Minami

Osaka Police Hospital - Department of Respiratory Medicine

Osaka

Japan

  • Osaka Police Hospital - Department of Respiratory Medicine

SCHOLARLY PAPERS

2

DOWNLOADS

78

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

A Randomized Phase Ii Trial of Standard Versus Low-Dose Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Cancer: JMTO LC14-01

Number of pages: 24 Posted: 07 Apr 2022
Susumu Takeuchi, Kaoru Kubota, Shunichi Sugawara, Satoshi Teramukai, Rintaro Noro, Kei Fujikawa, Takashi Hirose, Shinji Atagi, Seigo Minami, Shinichiro Iida, Hiroshi Kuraishi, Tomoiki Aiba, Yuji Minegishi, Masaru Matsumoto, Masahiro Seike, Akihiko Gemma and Masaaki Kawahara
Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Sendai Kousei Hospital - Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine - Department of Biostatistics, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Kyoto Prefectural University of Medicine - Department of Biostatistics, Nippon Medical School - Department of Pulmonary Medicine, National Hospital Organization - Department of Thoracic Oncology, Osaka Police Hospital - Department of Respiratory Medicine, Otemae Hospital - Department of Pulmonary Medicine, Nagano Red Cross Hospital - Department of Pulmonary Medicine, Sendai Kousei Hospital - Department of Pulmonary Medicine, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology and The Japan-Multinational Trial Organization (JMTO)
Downloads 40 (1,196,171)

Abstract:

Loading...

Non-small cell lung cancer, nab-paclitaxel, Low dose, Phase 2

2.

Randomized Phase II Trial of Standard Versus Low-Dose Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: JMTO LC14-01

Number of pages: 34 Posted: 25 Nov 2021
Susumu Takeuchi, Kaoru Kubota, Shunichi Sugawara, Satoshi Teramukai, Rintaro Noro, Kei Fujikawa, Takashi Hirose, Shinji Atagi, Seigo Minami, Shinichiro Iida, Hiroshi Kuraishi, Tomoiki Aiba, Yuji Minegishi, Masaru Matsumoto, Masahiro Seike, Akihiko Gemma and Masaaki Kawahara
Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Sendai Kousei Hospital - Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine - Department of Biostatistics, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Kyoto Prefectural University of Medicine - Department of Biostatistics, Nippon Medical School - Department of Pulmonary Medicine, National Hospital Organization - Department of Thoracic Oncology, Osaka Police Hospital - Department of Respiratory Medicine, Otemae Hospital - Department of Pulmonary Medicine, Nagano Red Cross Hospital - Department of Pulmonary Medicine, Sendai Kousei Hospital - Department of Pulmonary Medicine, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology and The Japan-Multinational Trial Organization (JMTO)
Downloads 38 (1,209,354)

Abstract:

Loading...

nab-paclitaxel, optimal dose, advanced NSCLC